Pegylated interferon alpha2b-induced skin eruption;Arzneimittelexanthem durch pegyliertes interferon-α2b

Hautarzt

Volumn 54, Issue 10, 2003, Pages 992-993

  Meller, S ^b   Erhardt, A ^b   Auci, A ^b   Neumann, N J ^b   Homey, B ^b   Megahed, M ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIOXIDANT; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ALLERGY; CASE REPORT; CELL TYPE; CLINICAL FEATURE; CONFERENCE PAPER; DRUG ERUPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; DRUG ERUPTIONS; EXANTHEMA; FEMALE; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MIDDLE AGED; OINTMENTS; POLYETHYLENE GLYCOLS; SKIN TESTS;

EID: 0141988988     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0600-8     Document Type: Conference Paper

References (11)

1. Baker DE (2001) Pegylated interferons. Rev Gastroenterol Disord 1:87-99
2. Berger L, Descamps V, Marck Y et al. (2000) Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports. Ann Dermatol Venereol 27:51-55
3. Dereure O, Raison-Peyron N, Larrey D et al. (2002) Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 147:1142-1146
4. Harris JM, Martin NE, Modi M (2001) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40:539-551
5. Lindsay KL, Trepo C, Heintges T et al. (2001) A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. Hepatology 34:395-403
6. Luxon BA, Grace M, Brassard D, Bordens R (2002) Pegylated interferons for the treatment of chronic hepatitis C infection. Clin Ther 24:1363-1383
7. Manjon-Haces JA, Vazquez-Lopez F, Gomez-Diez S et al. (2001) Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol 81:223
8. Pfeffer LM, Dinarello CA, Herberman RB et al. (1998) Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 58:2489-2499
9. Rubinowitz AN, Naidich DP, Alinsonorin C (2003) Case report. Interferon-induced sarcoidosis. J Comput Assist Tomogr 27:279-283
10. Taylor C, Burns DA, Wiselka MJ (2000) Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J 76:365-367
11. Youngster S, Wang YS, Grace M et al. (2002) Structure, biology, and therapeutic implications of pegylated interferon alpha-2b. Curr Pharm Des 8:2139-2157